Recording intelligenceAI-generated brief · check the source for context

Immune Drivers of Viral Emergence

1:00:21 recording · AUTO · 2 speakers

Listen to the original

Listen to the episode
Executive Summary AI
  • Cindy Leifer hosts an Immune office interview with Christian Anderson, professor in translational medicine at Scripps Research Institute, a T-cell immunologist turned expert in viral evolution.0:35
  • Anderson describes an unlikely path into science: the post office in Denmark and the Danish Royal Horse Guard, then free university study at Aarhus, and a four-year Cambridge PhD on regulatory T cells and the evolution of FOXP3.3:07
  • Sequencing the 2014 West African Ebola outbreak showed a single introduction dating to late December 2013 though it was only detected in March 2014, which meant closing markets selling bats removed a key protein source without removing the real risk, human-to-human contact.12:06
  • Once vaccination and infection built population immunity, the selection pressure on SARS-CoV-2 switched from being a better human virus, as with D614G and alpha, to breaking through the immunity wall, which is what Omicron did explosively.20:45
  • Anderson says that after the pandemic we are doing the opposite of preparing, stopping vaccine research and laying off public health staff, and calls it an anti-vaccine, anti-science agenda that scientists and institutions must confront together.34:20

Brief overview

Immunity is the strongest force shaping how viruses evolve, spill over and become pandemics.

  1. Immunity is the strongest selective force on virusesPopulation immunity turned SARS-CoV-2 evolution from transmissibility gains into immune escape, the same drift-and-shift logic that forces annual flu vaccines.
  2. Spillover risk rises with markets, cities and travelStressed animals moved into dense urban wet markets, forest encroachment, global travel and climate-driven vector spread all multiply the chances a spillover takes off.
  3. Vaccine protection is never all-or-nothingOf ten boosted people exposed maybe three get infected versus five unboosted, with shorter, milder infection and less onward transmission.

Questions this recording answers

10 questions, each answered where it is said
Where do new SARS-CoV-2 variants come from?

Andersen says variants most likely arise in chronic SARS-CoV-2 infections lasting months, largely in somewhat immunocompromised people. Inside that host the immune system keeps targeting the virus and the virus keeps evading, so immune selection dominates. But nothing transmits during that period, so the virus can lose transmissibility, stability being a key one.

Answered around 46:15
Why was Omicron so explosive?

Omicron probably started somewhat de-adapted for transmission but was very good at immune evasion. At that time everyone's immunity looked alike: the original Wuhan vaccine antigen, or infection with a close relative. Epitopes were shared, so escaping one person's immunity meant escaping the next person's. Omicron became by far the biggest wave, with the most deaths.

Answered around 47:39
Does a recent booster still lower your chance of catching COVID?

Yes. Andersen's example: expose ten recently boosted people and maybe three get infected; ten unboosted and maybe five do. People get infected in both groups, but fewer in one. If you are infected, the immune system responds faster, resolves it sooner and disease is milder. It is not 100 percent or 0 percent.

Answered around 52:17
How did population immunity change the way SARS-CoV-2 evolved?

Once vaccination and infection built immunity quickly, disease became less severe but the selection pressure shifted. The main thing was no longer binding ACE2 or optimising the polymerase for humans; it was breaking through an immunity wall. Delta was a hybrid example, Omicron the first big immune-escape variant, and that process has continued.

Answered around 20:45
Did Ebola enter West Africa once or several times in 2014?

Once. The first reported cases dated back to December 2013 although detection came in March 2014, and fitting a molecular clock to the genomes put the start exactly at late December. Everything traced to one common ancestor, in Guinea, unlike SARS-CoV-2, whose early lineages A and B are consistent with two spillovers.

Answered around 14:01
Were people catching Ebola from the bat markets that were closed?

No. Markets selling dried bats were shut down out of fear that people were getting Ebola from bats, but during the epidemic people were catching it from other people with Ebola. Only the first patient probably got it from a live bat. Showing this let the response focus on handwashing and hygiene instead of removing a main protein source.

Answered around 15:18
What human activities make spillovers and pandemics more likely?

Live animal markets, where stressed animals from many places are mixed, transported and sold in dense urban centres, all carrying viruses; population expansion and encroachment into forested areas, creating contact with animals and their viruses more and more often; and global travel, which can carry something like SARS-CoV-2 worldwide in hours or a few days.

Answered around 26:05
Why don't most spillovers turn into outbreaks?

Because SARS-CoV-2-like transmission is very clustered and rural human density is low, so the likelihood of causing the next infection is much less. A rural spillover may cause a handful of infections and then die out; they burn out. Andersen thinks this happens frequently with coronaviruses, flu viruses and others.

Answered around 27:37
Should the wild animal trade simply be banned?

Andersen agrees the trade is crazy, but banning it would not effectively stop it; it would move underground, where nothing can be monitored and detection is much harder. Livelihoods and food sources depend on it. He prefers better regulation: testing for viruses before animals reach markets, better husbandry, and not mixing certain animals together.

Answered around 32:17
How did a human gene lead Andersen to Lassa virus?

Pardis Sabeti's selection scans in humans found LARGE, part of Lassa virus's entry pathway, with long haplotypes risen to high frequency in West African populations, the signature of recent selection. Lassa is endemic there, so the question was whether those variants act as a restriction factor. Andersen then turned to the virus's own genomics.

Answered around 8:56
Key Quote

“It's that there's an immunity wall that you need to break through.”

— Christian Anderson, Immune Drivers of Viral Emergence, at 21:20▶ listen at 21:20
Key Quote

“The problem, of course, is that we're not doing any of that.”

— Christian Anderson, Immune Drivers of Viral Emergence, at 34:20▶ listen at 34:20
Key Quote

“The anti-science, anti-vax agenda, that's the problem.”

— Christian Anderson, Immune Drivers of Viral Emergence, at 41:36▶ listen at 41:36
Key Quote

“It's not either 100% or 0%.”

— Christian Anderson, Immune Drivers of Viral Emergence, at 53:42▶ listen at 53:42

Cite this

“Immune Drivers of Viral Emergence.” https://traffic.libsyn.com/secure/immune/ImmuneBooster019.mp3. Transcript summary by WhipScribe, https://whipscribe.com/transcript-pages/immune-drivers-of-viral-emergence.html.

Report this page
What is wrong with this page?